C Calmettes

1.0k total citations
53 papers, 724 citations indexed

About

C Calmettes is a scholar working on Endocrinology, Diabetes and Metabolism, Oncology and Surgery. According to data from OpenAlex, C Calmettes has authored 53 papers receiving a total of 724 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Oncology and 7 papers in Surgery. Recurrent topics in C Calmettes's work include Thyroid Cancer Diagnosis and Treatment (26 papers), Neuroendocrine Tumor Research Advances (7 papers) and Pituitary Gland Disorders and Treatments (7 papers). C Calmettes is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (26 papers), Neuroendocrine Tumor Research Advances (7 papers) and Pituitary Gland Disorders and Treatments (7 papers). C Calmettes collaborates with scholars based in France, Germany and Austria. C Calmettes's co-authors include E Modigliani, Brigitte Franc, R. Cohen, G. Milhaud, J Bigorgne, J.A. Chayvialle, J.C. Reubi, P Jallet, M.S. Moukhtar and Myriam Rosenberg‐Bourgin and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Cancer and Biochemical and Biophysical Research Communications.

In The Last Decade

C Calmettes

53 papers receiving 687 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C Calmettes France 13 485 291 269 143 142 53 724
Margareta Telenius‐Berg Sweden 11 277 0.6× 134 0.5× 148 0.6× 87 0.6× 54 0.4× 14 435
Ruth E. Farrell United States 7 345 0.7× 172 0.6× 141 0.5× 107 0.7× 69 0.5× 8 462
H A Bikkal United States 9 549 1.1× 220 0.8× 101 0.4× 65 0.5× 88 0.6× 10 724
Ulla Bergholm Sweden 15 454 0.9× 184 0.6× 172 0.6× 199 1.4× 59 0.4× 25 670
M Schlumberger France 11 373 0.8× 186 0.6× 133 0.5× 255 1.8× 125 0.9× 40 700
T Yäshiro Japan 13 186 0.4× 71 0.2× 110 0.4× 139 1.0× 35 0.2× 21 477
F. J. Seif Germany 10 271 0.6× 83 0.3× 126 0.5× 64 0.4× 38 0.3× 29 395
Eivind Carlsen United Kingdom 11 550 1.1× 215 0.7× 194 0.7× 77 0.5× 55 0.4× 19 676
Eleftherios Chatzellis Greece 11 350 0.7× 418 1.4× 222 0.8× 264 1.8× 234 1.6× 22 777
Hajime Kanauchi Japan 12 128 0.3× 83 0.3× 95 0.4× 220 1.5× 32 0.2× 25 529

Countries citing papers authored by C Calmettes

Since Specialization
Citations

This map shows the geographic impact of C Calmettes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Calmettes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Calmettes more than expected).

Fields of papers citing papers by C Calmettes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Calmettes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Calmettes. The network helps show where C Calmettes may publish in the future.

Co-authorship network of co-authors of C Calmettes

This figure shows the co-authorship network connecting the top 25 collaborators of C Calmettes. A scholar is included among the top collaborators of C Calmettes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Calmettes. C Calmettes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Modigliani, E, Hans F. A. Vasen, Henning Dralle, et al.. (1995). Pheochromocytoma in multiple endocrine neoplasia type 2: European study. Journal of Internal Medicine. 238(4). 363–367. 120 indexed citations
2.
Guliana, J.M., J. Taboulet, C Calmettes, et al.. (1994). Heterogeneity of circulating calcitonin levels: relations with calcitonin biosynthesis in medullary thyroid carcinomas. Nuclear Medicine and Biology. 21(3). 359–368. 5 indexed citations
3.
Casanova, S., Myriam Rosenberg‐Bourgin, C Calmettes, et al.. (1993). Phaeochromocytoma in multiple endocrine neoplasia type 2 A: survey of 100 cases. Clinical Endocrinology. 38(5). 531–537. 67 indexed citations
4.
Calmettes, C, Bruce A.J. Ponder, Fischer Ja, & Friedhelm Raue. (1992). Early diagnosis of the multiple endocrine neoplasia type 2 syndrome: consensus statement. European Journal of Clinical Investigation. 22(11). 755–760. 28 indexed citations
5.
Guilloteau, Denis, R. Perdrisot, C Calmettes, et al.. (1990). Diagnosis of Medullary Carcinoma of the Thyroid (MCT) by Calcitonin Assay Using Monoclonal Antibodies: Criteria for the Pentagastrin Stimulation Test in Hereditary MCT. The Journal of Clinical Endocrinology & Metabolism. 71(4). 1064–1067. 57 indexed citations
6.
Modigliani, E, S. Casanova, J.A. Chayvialle, et al.. (1990). Immunoreactive Gastrin-Releasing Peptide in Medullary Thyroid Carcinoma. The Journal of Clinical Endocrinology & Metabolism. 71(4). 831–835. 14 indexed citations
7.
Modigliani, E, C Alamowitch, R. Cohen, et al.. (1990). The intratumoral immunoassayable somatostatin concentration is frequently elevated in medullary thyroid carcinoma results in 34 cases. Cancer. 65(2). 224–228. 12 indexed citations
8.
Guliana, J.M., et al.. (1989). Effects of Short-Term Subcutaneous Administration of SMS 201-995 on Calcitonin Plasma Levels in Patients Suffering from Medullary Thyroid Carcinoma. Hormone and Metabolic Research. 21(10). 584–586. 12 indexed citations
9.
Sobol, Hagay, Steven A. Narod, David Assouline, Gilbert Lenoir, & C Calmettes. (1989). Genetic Screening of Endocrine Tumour Syndromes with DNA Probes: The Example of Medullary Thyroid Carcinoma. Hormone Research. 32(1-3). 34–40. 2 indexed citations
10.
Calmettes, C. (1989). Multiple Endocrine Neoplasia Type II: Clinical, Biological and Epidemiological Features. Hormone Research. 32(1-3). 41–46. 1 indexed citations
11.
Calmettes, C, et al.. (1989). Early calcitonin hypersecretion and C cell hyperplasia in rats with high incidence of C cell tumors (Wag/Rij). Bone and Mineral. 6(3). 249–260. 7 indexed citations
12.
13.
Roussey, M., et al.. (1981). [Thyroid cancer with amyloid stroma, Sipple's syndrome, congenital megacolon with plexus hyperplasia: one and the same dominant autosomal disease with complete penetrance].. PubMed. 28(5). 169–74. 2 indexed citations
14.
Israël, Lucien, A Depierre, C Calmettes, & G. Milhaud. (1977). Sécrétion de calcitonine par des cancers testiculaires.. ˜La œNouvelle presse médicale. 6(41). 3866–3866. 1 indexed citations
15.
Eyquem, A, et al.. (1977). [Calcitonin in the ultimobrancial body of Anguilla (Anguilla anguilla L.): cytologic localization by indirect immunofluorescence using human anti-salmon-calcitonin antibodies].. PubMed. 285(1). 81–4. 1 indexed citations
16.
Calmettes, C, et al.. (1977). Correlation between calcitonin and carcinoembryonic antigen levels in medullary carcinoma of the thyroid.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 27(2). 52–4. 16 indexed citations
17.
Moukhtar, M.S., Amandine Jullienne, J. Taboulet, et al.. (1975). Hétérogénéité de la calcitonine immunoréactive dans le plasma de sujets avec cancer médullaire. Pathologie Biologie. 23(10). 2 indexed citations
18.
Milhaud, G., C Calmettes, & M.S. Moukhtar. (1970). Sécrétion ectopique de thyrocalcitonine.. 90(7). 1 indexed citations
19.
Milhaud, G, et al.. (1970). [Thyrocalcitonin-secreting carcinoid].. PubMed. 18. 2195–8. 4 indexed citations
20.
Milhaud, G., C Calmettes, Gideon Dreyfuss, & M.S. Moukhtar. (1970). An unusual trabecular thyroid cancer producing calcitonin. Cellular and Molecular Life Sciences. 26(12). 1381–1383. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Margareta Telenius‐Berg Breakdown of academic impact, for papers by Ruth E. Farrell Breakdown of academic impact, for papers by H A Bikkal Breakdown of academic impact, for papers by Ulla Bergholm Breakdown of academic impact, for papers by M Schlumberger Breakdown of academic impact, for papers by T Yäshiro Breakdown of academic impact, for papers by F. J. Seif Breakdown of academic impact, for papers by Eivind Carlsen Breakdown of academic impact, for papers by Eleftherios Chatzellis Breakdown of academic impact, for papers by Hajime Kanauchi
Rankless by CCL
2026